AHA, others urge Congress to fund CSR payments

AHA News Now

The AHA and seven other national organizations this weekend urged congressional leaders to “take action now to fund cost-sharing reduction benefits for the millions of Americans who depend on this critical program.” The White House announced last week that it will stop making CSR payments to health... read more

Topic: Access and Coverage
Tag: price

Changing 340B is the wrong prescription for addressing skyrocketing pharmaceutical costs

Blog

The rapidly rising costs of prescription drugs is causing significant financial challenges for patients and their care providers.

Many groups, including the AHA, are evaluating options for addressing this important issue. However, one recent proposal, which is seriously misguided, would reduce a program... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access, price, drug prices

Complex Care Found at Facilities Affiliated with Hospitals and Health Systems

Blog

A recent study that claims cancer care is more expensive because hospitals are employing more physicians is misleading and does not consider all of the facts. 

The study had several problematic areas. While it accounts for changes in the general rate of inflation, there is no indication that the authors... read more

Topic: Access and Coverage
Tags: mergers, site neutral payment, price, care coordination

Stop Unsustainable Drug Prices

Blog

Today’s New York Times provides arguments from drug companies justifying the excessive jump in pharmaceutical prices in recent years, saying the higher prices won’t impact patients. 

Hospitals’ top priority is providing patients with safe and effective care, but the skyrocketing costs of pharmaceuticals... read more

Topic: Access and Coverage
Tags: access, price, drug prices

Study finds no systematic quantifiable relationship between price and concentration

Blog

A new study out today conflicts head on with an April 2015 study by a leading health care expert and antitrust economist that found “concentration or structure alone is not a meaningful or reliable predictor of price changes.”  Both studies relied on commercial data, but the latter had authors who were... read more

Topic: Access and Coverage
Tag: price

Protect Patients. Preserve 340B.

Blog

More than 20 years ago, Congress created the 340B Drug Pricing Program to allow eligible hospitals and health systems to stretch limited resources and expand access to care for vulnerable patients. But despite a proven track record of increasing patient access to vital medical services and decreasing... read more

Topic: Access and Coverage
Tags: 340B, Drug Pricing Program, access, price, drug prices

Mega Insurance Deals Not Good for Consumers

Blog

The recently announced mega deals in the insurance industry will lead to further consolidation of an already highly concentrated health insurance market and will not benefit consumers says an opinion piece in Law360. The column, authored by former policy director of the Bureau of Competition at the... read more

Topics: Access and Coverage, Community Health
Tags: acquisitions, mergers, Coverage, access, price, clinical integration, care coordination, antitrust

Who benefits from insurance mega-deals?

Blog

Recent announcements about commercial insurance company acquisitions continue to send up red flags and with good reason. The question on everyone’s mind is: How can these mega-deals possibly benefit consumers? The insurance industry already is enormously concentrated and has a dismal track record of... read more

Topic: Access and Coverage
Tags: acquisitions, consolidation, mergers, Coverage, access, price, antitrust

A Little Good, a Little Bad

Blog

The news often brings some good and some bad; sometimes a step forward and a step back. This week’s good news is the proposed change that would allow payment for advanced care planning visits with clinicians, encouraging dialogs that will help patients determine how they want care provided in serious... read more

Topics: Access and Coverage, Advocacy and Public Policy
Tags: physician issues, physicians, Drug Pricing Program, advocacy, financial assistance, price

Transparency is Good for Patients

Blog

The AHA has long supported the need to provide patients with health care price and quality information and has worked with stakeholders to provide useful information that will help patients make health care decisions. It will take everyone -- providers, insurers, employers and government -- working... read more

Topic: Access and Coverage
Tags: Coverage, access, price, transparency

Keyword Search

Date